Former rivals Imaging Advantage and RadNet are joining forces to bring lower costs to MRI scans, and help avoid unnecessary testing, as US medicine moves away from a fee-for-service to a value-based healthcare payment model. The two companies announced the deal on Tuesday at an event in New York City hosted by the American Society for Clinical Oncology.
Former rivals Imaging Advantage and RadNet are joining forces to bring lower costs to MRI scans, and help avoid unnecessary testing, as US medicine moves away from a fee-for-service to a value-based healthcare payment model. Imaging Advantage, backed by Goldman Sachs signed the deal with RadNet to provide a 17-minute turnaround time for patients, utilising a cloud-based infrastructure producing 2 million exams per year.